Emerald Mutual Fund Advisers Trust’s ANI Pharmaceuticals ANIP Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-145,276	Closed	-$8.43M	–	240
2023 Q3	$8.43M	Hold	145,276	–	–	0.51%	87
2023 Q2	$7.82M	Sell	145,276 -161,001	-53%	-$7.14M	0.42%	90
2023 Q1	$12.2M	Sell	306,277 -25,414	-8%	-$1.07M	0.72%	63
2022 Q4	$13.3M	Sell	331,691 -6,707	-2%	-$252K	0.83%	54
2022 Q3	$10.9M	Sell	338,398 -18,467	-5%	-$632K	0.69%	62
2022 Q2	$10.6M	Buy	356,865 +57,372	+19%	+$1.65M	0.61%	68
2022 Q1	$8.42M	Buy	299,493 +210,002	+235%	+$7.83M	0.37%	95
2021 Q4	$4.12M	Buy	+89,491	New	+$3.85M	0.15%	133
2014 Q4	–	Sell	-104,134	Closed	-$2.94M	–	214
2014 Q3	$2.94M	Hold	104,134	–	–	0.28%	108
2014 Q2	$3.59M	Buy	104,134 +41,857	+67%	+$1.31M	0.33%	100
2014 Q1	$1.95M	Buy	+62,277	New	+$1.65M	0.19%	123

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ANIP Position: Q4 2023 in Review

Emerald Mutual Fund Advisers Trust sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 145,276 shares — an estimated $8.43M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ANIP in Q1 2014 and held it in 11 quarters. The position peaked at $13.3M in Q4 2022. 181 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

Emerald Mutual Fund Advisers Trust reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 145,276 ANI Pharmaceuticals shares in Q4 2023, an estimated $8.43M.
Emerald Mutual Fund Advisers Trust first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 11 quarters.
Emerald Mutual Fund Advisers Trust's ANI Pharmaceuticals position peaked at $13.3M in Q4 2022.
181 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2023, filed 5 Feb 2024.